Literature DB >> 20557988

Therapeutic strategies for heart failure in cardiorenal syndromes.

Andrew A House1, Mikko Haapio, Johan Lassus, Rinaldo Bellomo, Claudio Ronco.   

Abstract

Cardiorenal syndromes are disorders of the heart and kidneys whereby acute or long-term dysfunction in one organ may induce acute or long-term dysfunction of the other. The management of cardiovascular diseases and risk factors may influence, in a beneficial or harmful way, kidney function and progression of kidney injury. In this review, we assess therapeutic strategies and discuss treatment options for the management of patients with heart failure with decreased kidney function and highlight the need for future high-quality studies in patients with coexisting heart and kidney disease.
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20557988     DOI： 10.1053/j.ajkd.2010.04.012

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


  13 in total

Review 1.  Basic science: Pathophysiology: the cardiorenal metabolic syndrome.

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2014-07-05

2.  Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.

Authors:  Ryo Watanabe; Jun-Ichi Suzuki; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Issei Komuro; Mitsuaki Isobe
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

Review 3.  Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.

Authors:  Toshinori Aoyagi; Takashi Matsui
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 4.  Loop diuretics in chronic heart failure: how to manage congestion?

Authors:  Justas Simonavičius; Christian Knackstedt; Hans-Peter Brunner-La Rocca
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

5.  The Role of Overweight and Obesity in the Cardiorenal Syndrome.

Authors:  James R Sowers; Adam Whaley-Connell; Melvin R Hayden
Journal:  Cardiorenal Med       Date:  2011-01-17       Impact factor: 2.041

6.  Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.

Authors:  Alberto Palazzuoli; Marco Pellegrini; Beatrice Franci; Matteo Beltrami; Gaetano Ruocco; Stefano Gonnelli; Gianni D Angelini; Ranuccio Nuti
Journal:  Intern Emerg Med       Date:  2014-08-03       Impact factor: 3.397

Review 7.  Cardiorenal syndrome: new developments in the understanding and pharmacologic management.

Authors:  Andrew A House
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 8.237

8.  Vascular damage in kidney disease: beyond hypertension.

Authors:  Andréa E M Stinghen; Roberto Pecoits-Filho
Journal:  Int J Hypertens       Date:  2011-08-14       Impact factor: 2.420

9.  Relationship between drug application and mortality rate in Chinese older coronary artery disease/chronic heart failure patients with and without low glomerular filtration rate.

Authors:  Shihui Fu; Ping Ping; Ping Ye; Leiming Luo
Journal:  BMC Pharmacol Toxicol       Date:  2019-07-26       Impact factor: 2.483

10.  Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.

Authors:  Alberto Palazzuoli; Marco Pellegrini; Gaetano Ruocco; Giuseppe Martini; Beatrice Franci; Maria Stella Campagna; Marilyn Gilleman; Ranuccio Nuti; Peter A McCullough; Claudio Ronco
Journal:  Crit Care       Date:  2014-06-28       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.